We are live on ! Find out more
GS

George Soros Soros Fund Management

AUM $8.14B
1-Year Est. Return 35.85%
 

George Soros is the founder of Soros Fund Management and one of the most famous macro investors in modern markets. He is best known for large global bets informed by his theory of reflexivity, including the 1992 sterling trade. Though the firm later evolved as a family office, its equity filings and historical track record remain a reference point for students of macro and activist-era hedge funds.

This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+35.85%
3 Year Est. Return
+90.09%
5 Year Est. Return
+79.07%
10 Year Est. Return
+604.71%
AUM
$6.02B
AUM Growth
-$1.63B
Cap. Flow
-$2.86B
Cap. Flow %
-47.53%
Top 10 Hldgs %
29.65%
Holding
274
New
78
Increased
32
Reduced
34
Closed
81

Top Buys

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.5M
2
ARMK icon
Aramark
ARMK
+$46.4M
3
WRK
WestRock Company
WRK
+$39.3M
4
OKTA icon
Okta
OKTA
+$39.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.8M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$241M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$239M
3
NVO
Novo Nordisk
NVO
+$90.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$82.4M
5
FEZ icon
State Street SPDR EURO STOXX 50 ETF
FEZ
+$65.7M

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Industrials 7.12%
3 Financials 5.45%
4 Communication Services 5.11%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPSB icon
151
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
$1.66M 0.03%
55,800
– –
STVN icon
152
Stevanato
STVN
$6.17B
$1.44M 0.02%
+45,000
New +$1.37M
CRGY icon
153
Crescent Energy
CRGY
$4.65B
$1.19M 0.02%
+99,990
New +$1.13M
SYRE icon
154
Spyre Therapeutics
SYRE
$9.39B
$1.14M 0.02%
+30,038
New +$870K
NEE icon
155
NextEra Energy
NEE
$174B
$1.08M 0.02%
+16,904
New +$990K
PRGS icon
156
Progress Software
PRGS
$1.82B
$753K 0.01%
+14,120
New +$775K
SOLV icon
157
Solventum
SOLV
$15.2B
$696K 0.01%
+10,000
New +$749K
MDGL icon
158
Madrigal Pharmaceuticals
MDGL
$11.9B
$538K 0.01%
+2,016
New +$475K
APLS
159
DELISTED
Apellis Pharmaceuticals
APLS
$526K 0.01%
+8,948
New +$570K
ASND icon
160
Ascendis Pharma A/S
ASND
$16.6B
$519K 0.01%
+3,432
New +$490K
XLF icon
161
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
$517K 0.01%
12,270
– –
SRPT icon
162
Sarepta Therapeutics
SRPT
$1.98B
$512K 0.01%
+3,956
New +$485K
BOLD
163
Boundless Bio
BOLD
$68.2M
$285K ﹤0.01%
+20,000
New +$285K
UTHR icon
164
United Therapeutics
UTHR
$22B
$242K ﹤0.01%
+1,054
New +$238K
AAPL icon
165
PUT
Apple
AAPL
$4.51T
– –
-275,000
Closed -$52.9M
APTV icon
166
Aptiv
APTV
$10B
– –
-58,972
Closed -$5.29M
ARRY icon
167
Array Technologies
ARRY
$722M
– –
-180,000
Closed -$3.02M
AX icon
168
CALL
Axos Financial
AX
$5.48B
– –
-300,000
Closed -$16.4M
BABA icon
169
Alibaba
BABA
$286B
– –
-75,000
Closed -$5.49M
BAM icon
170
CALL
Brookfield Asset Management
BAM
$83.5B
– –
-150,000
Closed -$6.03M
BAM icon
171
Brookfield Asset Management
BAM
$83.5B
– –
-1
Closed -$40
BIRK icon
172
Birkenstock
BIRK
$5.89B
– –
-625,000
Closed -$30.5M
CI icon
173
Cigna
CI
$73.3B
– –
-45,000
Closed -$13.5M
CMPR icon
174
Cimpress
CMPR
$2.13B
– –
-5,000
Closed -$400K
COF icon
175
PUT
Capital One
COF
$134B
– –
-445,000
Closed -$58.3M
5 6
7
8 9

Similar funds

EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

George Soros's Q1 2024 Portfolio in Review

As of Q1 2024, George Soros held 274 positions worth $6.02B, down 21% from $7.65B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

George Soros withdrew a net $2.86B in Q1 2024, closing 81 positions and reducing 34 holdings. Its most notable exit was Splunk Inc, an estimated $241M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5% a quarter earlier, followed by Industrials and Financials.

Against the trend, George Soros opened a new position in Cerevel Therapeutics Holdings, Inc. Common Stock worth $82M.

  • George Soros's largest Q1 2024 buy was Cerevel Therapeutics Holdings, Inc. Common Stock: 1,940,201 shares worth $82M.
  • George Soros added most to Aramark in Q1 2024, an estimated $46.4M increase.
  • George Soros's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $90.1M.
  • George Soros fully exited Splunk Inc in Q1 2024, selling an estimated $241M.
  • George Soros's ten largest holdings make up 30% of its $6.02B portfolio in Q1 2024.
  • George Soros opened 78 new positions and closed 81 in Q1 2024.
  • George Soros's portfolio value fell 21% quarter-over-quarter to $6.02B.

Based on Soros Fund Management's 13F filing for Q1 2024, filed 15 May 2024.